World News: 22:10 GMT Wednesday 13th June 2018. [Novavax, Inc. via Thomson Reuters ONE via SPi World News]
NanoFluTMPhase 12 trial data published in a peer-reviewed letter to the editor inThe New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and drifted AH3N2 influenza viruse...
More news and information about Novavax, Inc.
Thomson Reuters: 22:10 GMT Wednesday 13th June 2018
Published: 2018-06-13T22:10:41.
Search for other references to "england" on SPi News
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us